ACADEMY OF MANAGED CARE PHARMACY for ACADEMY OF MANAGED CARE PHARMACY
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report | Oct 12, 2018 | $50,000 | Replaced |
| 3rd Quarter - Amendment (this page) | Oct 17, 2018 | $50,000 | Replaced |
| 3rd Quarter - Amendment | Nov 9, 2018 | $50,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Met with HHS officials regarding the Administration Blueprint to Lower Drug Prices. Submitted comments to HHS in response to Blueprint. Communications and correspondence related to suspension of claims under Medicare Part D for a credible allegation of fraud, electronic prescribing, and prior authorization under Medicare Part D contained in HR 6--The Opioid Crisis Response Act of 2018.
| Lobbyist | Covered position, as disclosed |
|---|---|
| REGINIA GRAYSON BENJAMIN | Director of Legislative Affairs |
| MARY JO CARDEN | Vice President, Government & Pharmacy Affairs |
Pharmacy PHA
Sent a letter in support of S. 974, the CREATES Act to the full Senate and communicated in regard to the bill. Dissemination of information in support of H.R. 2026 - Pharmaceutical Information Exchange Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| REGINIA GRAYSON BENJAMIN | — |
| MARY JO CARDEN New | Vice President, Government & Pharmacy Affairs |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.